Nanosized CuO encapsulated Ni/Co bimetal Prussian blue with high anti-interference and stability for electrochemical non-enzymatic glucose detection

Research progress on the synthesis, performance regulation, and applications of Prussian blue nanozymes

Nanocatalytic medicine offers a novel solution to address the issues of low efficacy, potential side effects, and the development of drug resistance associated with traditional therapies. Therefore, developing highly efficient and durable nanozymes is of great significance for treating diseases related to oxidative stress. In recent years, prussian blue nanoparticles (PBNPs) have been demonstrated to possess multiple enzyme-like catalytic activities and are thus referred to as prussian blue nanozymes (PBNZs). Their excellent biocompatibility and biodegradability make PBNZs promising candidates as biomedical materials. Due to their remarkable catalytic activities, PBNZs have shown great potential in various biomedical applications, such as heavy metal detoxification, antioxidative damage, and anticancer therapies. This paper systematically summarizes the Synthetic strategies of PBNZs, analyzes the regulatory factors of their catalytic performance, and highlights the corresponding modulation methods. Furthermore, the biomedical applications of PBNZs are also reviewed. This study aims to provide researchers with insights and inspirations for the design and preparation of high-performance PBNZs.

Electrochemical Glucose Sensors: Classification, Catalyst Innovation, and Sampling Mode Evolution

Glucose sensors are essential tools for monitoring blood glucose concentration in diabetic patients. In recent years, with the increasing number of individuals suffering from diabetes, blood glucose monitoring has become extremely necessary, which expedites the iteration and upgrade of glucose sensors greatly. Currently, two main types of glucose sensors are available for blood glucose testing: enzyme-based glucose sensor (EBGS) and enzyme-free glucose sensor (EFGS). For EBGS, several progresses have been made to comprehensively improve detection performance, ranging from enhancing enzyme activity, thermostability, and electron transfer properties, to introducing new materials with superior properties. For EFGS, more and more new metallic materials and their oxides are being applied to further optimize its blood glucose monitoring. Here the latest progress of electrochemical glucose sensors, their manufacturing methods, electrode materials, electrochemical parameters, and applications were summarized, the development glucose sensors with various noninvasive sampling modes were also compared.

Enzyme-free electrochemical sensor platforms based on transition metal nanostructures for clinical diagnostics

The detection of emergent biomarkers is of key significance in numerous clinical, biological, and biomedical fields. Specifically, the design and development of potent electrochemical lactic acid and glucose sensing platforms are especially in great demand in a variety of industries, including those involved in clinical analysis, biomedicine, biological, food, cosmetics, pharmaceuticals, leather, sports, and chemical industries. Nanostructured transition metal-derived materials have opened the door to electrochemical sensors and biosensors due to their advantages of high surface-to-volume ratio, surface reaction activity, catalytic activity, and strong adsorption capability. The primary aim of the present minireview is to highlight the advancement of enzyme-free electrochemical sensor platforms based on transition metal-derived nanostructures with high electrocatalytic activity and sensing performance towards lactic acid and glucose in practical samples. The preparation approaches, structural and composition monitoring, fabrication of sensing electrodes, catalytic activity, sensing performance in real samples, and the exploration of sensing mechanisms are majorly concentrated on in most of our recent research studies. Moreover, state-of-the-art transition metal-derived nanostructure-derived electrochemical sensor platforms, critical comparison of the analytical performance of the sensor platforms, and the future perspectives of the enzyme-free electrochemical sensor for clinical diagnostics are described.

A non-enzymatic glucose sensor based on a mesoporous carbon sphere immobilized Co-MOF-74 nanocomposite

Exploration of credible non-enzymatic glucose sensors with high selectivity and sensitivity is of great significance for early clinical monitoring of glucose concentration and preventing the threat of diabetes to human health. Here, mesoporous carbon (MC) sphere immobilized Co-MOF-74 nanorods (NRs), denoted as Co-MOF-74 NRs/MC, were successfully prepared, in which the nanostructural porous carbon sphere was obtained using cobalt glycolate as the built-in template followed by a subsequent carbonization and acid treatment, and the MC spheres were then in situ deposited on the surface of Co-MOF-74 NRs via a solvothermal method. Benefiting from the good conductivity of the grafted porous carbon spheres and the abundant active sites, as well as the permeability of microporous MOF-74 nanocrystals, the Co-MOF-74 NRs/MC modified glassy carbon electrode (GCE) exhibited effective non-enzymatic glucose sensing performance with a fast response time (less than 3 s) and a glucose sensitivity of 98.0 μA cm-2 mM-1. Furthermore, the Co-MOF-74 NRs/MC/GCE showed a favourable anti-interference capability in the presence of various interferents and good long-term reusability. The applicability of Co-MOF-74 NRs/MC/GCE for glucose sensing in real serum samples was also investigated, verifying the applicability of the electrode for targeted glucose monitoring in practical applications.

Electrospinning One-dimensional Surface-phosphorized CuCo/C nanofibers for Enzyme-free Glucose Sensing

Developing novel electrocatalysts is of great importance for the practical application of non-enzymatic glucose sensors. One-dimensional (1D) carbon fiber-supported copper-cobalt bimetallic electrocatalysts (CuCo-P350) are successfully prepared via electrospinning technology and...

Bimetallic Nanomaterials-Based Electrochemical Biosensor Platforms for Clinical Applications

Diabetes is a foremost health issue that results in ~4 million deaths every year and ~170 million people suffering globally. Though there is no treatment for diabetes yet, the blood glucose level of diabetic patients should be checked closely to avoid further problems. Screening glucose in blood has become a vital requirement, and thus the fabrication of advanced and sensitive blood sugar detection methodologies for clinical analysis and individual care. Bimetallic nanoparticles (BMNPs) are nanosized structures that are of rising interest in many clinical applications. Although their fabrication shares characteristics with physicochemical methodologies for the synthesis of corresponding mono-metallic counterparts, they can display several interesting new properties and applications as a significance of the synergetic effect between their two components. These applications can be as diverse as clinical diagnostics, anti-bacterial/anti-cancer treatments or biological imaging analyses, and drug delivery. However, the exploitation of BMNPs in such fields has received a small amount of attention predominantly due to the vital lack of understanding and concerns mainly on the usage of other nanostructured materials, such as stability and bio-degradability over extended-time, ability to form clusters, chemical reactivity, and biocompatibility. In this review article, a close look at bimetallic nanomaterial based glucose biosensing approaches is discussed, concentrating on their clinical applications as detection of glucose in various real sample sources, showing substantial development of their features related to corresponding monometallic counterparts and other existing used nanomaterials for clinical applications.